Clinical Trials Directory

Trials / Completed

CompletedNCT00882427

Blood Glucose Control Over an Extended Glucose Control Range in Postoperative Cardiac Surgery Patients in the Intensive Care Unit

Single-center, Open Study on the Performance of the Software eMPC Algorithm Used for Blood Glucose Control Over an Extended Glucose Control Range (4.4 to 8.3 mmol/L) for a Maximum of 48 Hours in Postoperative Cardiac Surgery Patients in the Intensive Care Unit

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
B. Braun Melsungen AG · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hyperglycaemia is commonly found in critically ill patients. Clinical studies demonstrated that tight blood glucose control in medical and surgical ICU patients results in a significant better outcome for the patients. Based on this emerging clinical evidence, there are increasing efforts worldwide to maintain strict glycaemic control in critically ill patients. However, achieving this goal requires extensive nursing efforts, including frequent bedside glucose monitoring and the implementation of complex intensive insulin infusion protocols. A fully automated algorithm may help to overcome some of these limitations by excluding intuitive interventions and integrating relevant clinical data in the decision-making process. This study will investigate the performance of an eMPC algorithm adjusted to target the range 4.4 - 8.3 mmol/L in line with the Surviving Sepsis guidelines.

Conditions

Interventions

TypeNameDescription
OTHERenhanced model predictive control algorithm (eMPC)eMPC (software on a bedside computer) advised insulin titration to establish tight glycaemic control

Timeline

Start date
2009-03-01
Primary completion
2009-07-01
Completion
2009-07-01
First posted
2009-04-16
Last updated
2010-02-05

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00882427. Inclusion in this directory is not an endorsement.